作者: Serge GlaxoSmithKline Biologicals S.A. Debrus , Martine Anne Cécile Wettendorff , Marie-Therese Martin , Robert John GlaxoSmithKline Stephen , Jean Glaxosmithkline Biologicals S.A. Stephenne
DOI:
关键词:
摘要: An immunogenic composition and methods for producing said composition, the comprising VLPs from HPV 16 18 at least one other cancer type, type being selected list consisting of types 31, 45 52, wherein dose VLP is reduced relative to that or 18.